Annual SGA
$7.16 M
-$149.00 K-2.04%
December 31, 2022
Summary
- As of February 7, 2025, ARDS annual SGA is $7.16 million, with the most recent change of -$149.00 thousand (-2.04%) on December 31, 2022.
- During the last 3 years, ARDS annual SGA has risen by +$1.14 million (+18.84%).
- ARDS annual SGA is now -2.04% below its all-time high of $7.31 million, reached on December 31, 2021.
Performance
ARDS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.11 M
-$199.00 K-15.19%
September 30, 2023
Summary
- As of February 7, 2025, ARDS quarterly SGA is $1.11 million, with the most recent change of -$199.00 thousand (-15.19%) on September 30, 2023.
- Over the past year, ARDS quarterly SGA has dropped by -$199.00 thousand (-15.19%).
- ARDS quarterly SGA is now -48.59% below its all-time high of $2.16 million, reached on March 31, 2022.
Performance
ARDS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$778.91 M
-$1.14 M-0.15%
September 30, 2023
Summary
- As of February 7, 2025, ARDS TTM SGA is -$778.91 million, with the most recent change of -$1.14 million (-0.15%) on September 30, 2023.
- Over the past year, ARDS TTM SGA has dropped by -$785.35 million (-12189.20%).
- ARDS TTM SGA is now -1535.47% below its all-time high of -$47.63 million.
Performance
ARDS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ARDS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.0% | -15.2% | -10000.0% |
| 3 y3 years | +18.8% | -31.9% | -10000.0% |
| 5 y5 years | +126.6% | -19.7% | -10000.0% |
ARDS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.0% | at low | -48.6% | at low | -32.6% | at low |
| 5 y | 5-year | -2.0% | +18.8% | -48.6% | at low | -114.8% | at low |
| alltime | all time | -2.0% | +264.4% | -48.6% | +72.5% | -1535.5% | at low |
Aridis Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $1.11 M(-15.2%) | $5.86 M(-9.0%) |
| Jun 2023 | - | $1.31 M(-27.8%) | $6.44 M(-5.4%) |
| Mar 2023 | - | $1.81 M(+11.6%) | $6.81 M(-4.8%) |
| Dec 2022 | $7.16 M(-2.0%) | $1.63 M(-4.0%) | $7.16 M(-4.6%) |
| Sep 2022 | - | $1.69 M(+0.7%) | $7.51 M(-0.1%) |
| Jun 2022 | - | $1.68 M(-22.2%) | $7.51 M(-0.2%) |
| Mar 2022 | - | $2.16 M(+9.5%) | $7.53 M(+3.0%) |
| Dec 2021 | $7.31 M(+13.4%) | $1.97 M(+16.1%) | $7.31 M(+5.5%) |
| Sep 2021 | - | $1.70 M(+0.3%) | $6.93 M(+1.0%) |
| Jun 2021 | - | $1.69 M(-12.9%) | $6.86 M(+1.6%) |
| Mar 2021 | - | $1.94 M(+22.1%) | $6.75 M(+4.7%) |
| Dec 2020 | $6.45 M | $1.59 M(-2.4%) | $6.45 M(+3.3%) |
| Sep 2020 | - | $1.63 M(+3.0%) | $6.24 M(+4.1%) |
| Jun 2020 | - | $1.58 M(-3.4%) | $5.99 M(-0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $1.64 M(+18.1%) | $6.02 M(-0.0%) |
| Dec 2019 | $6.03 M(+55.5%) | $1.39 M(+0.3%) | $6.03 M(+0.0%) |
| Sep 2019 | - | $1.38 M(-14.2%) | $6.02 M(+12.1%) |
| Jun 2019 | - | $1.61 M(-1.7%) | $5.37 M(+20.8%) |
| Mar 2019 | - | $1.64 M(+18.5%) | $4.45 M(+14.8%) |
| Dec 2018 | $3.87 M(+22.6%) | $1.39 M(+88.4%) | $3.87 M(+23.7%) |
| Sep 2018 | - | $735.00 K(+7.0%) | $3.13 M(+2.8%) |
| Jun 2018 | - | $687.00 K(-35.6%) | $3.05 M(-4.5%) |
| Mar 2018 | - | $1.07 M(+65.5%) | $3.19 M(+1.2%) |
| Dec 2017 | $3.16 M(+60.8%) | $644.00 K(-0.8%) | $3.15 M(+25.7%) |
| Sep 2017 | - | $649.00 K(-21.7%) | $2.50 M(+35.0%) |
| Jun 2017 | - | $829.00 K(-19.3%) | $1.86 M(+80.7%) |
| Mar 2017 | - | $1.03 M | $1.03 M |
| Dec 2016 | $1.97 M | - | - |
FAQ
- What is Aridis Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals annual SGA year-on-year change?
- What is Aridis Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals quarterly SGA year-on-year change?
- What is Aridis Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals TTM SGA year-on-year change?
What is Aridis Pharmaceuticals annual SGA?
The current annual SGA of ARDS is $7.16 M
What is the all time high annual SGA for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high annual SGA is $7.31 M
What is Aridis Pharmaceuticals annual SGA year-on-year change?
Over the past year, ARDS annual SGA has changed by -$149.00 K (-2.04%)
What is Aridis Pharmaceuticals quarterly SGA?
The current quarterly SGA of ARDS is $1.11 M
What is the all time high quarterly SGA for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high quarterly SGA is $2.16 M
What is Aridis Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ARDS quarterly SGA has changed by -$199.00 K (-15.19%)
What is Aridis Pharmaceuticals TTM SGA?
The current TTM SGA of ARDS is -$778.91 M
What is the all time high TTM SGA for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high TTM SGA is -$47.63 M
What is Aridis Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ARDS TTM SGA has changed by -$785.35 M (-12189.20%)